Form 4: Edgewell Personal Care Director Rakesh Sachdev Reports Acquisition of Restricted Stock Equivalents

Sentiment:

SEC Filing


Director Rakesh Sachdev reports acquiring 4,999 restricted stock equivalents of Edgewell Personal Care Co on February 6, 2025.

Summary

  • Rakesh Sachdev, a director of Edgewell Personal Care Co, filed a Form 4 with the SEC.
  • The filing reports the acquisition of 4,999 restricted stock equivalents on February 6, 2025.
  • These restricted stock equivalents convert into shares of Edgewell Common Stock the day before the next annual shareholder meeting, unless conversion is deferred until termination of board service.
  • The reporting person directly owns 4,999 of these securities.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing reflecting a standard compensation practice. It doesn't inherently indicate positive or negative sentiment.

Future Outlook

The restricted stock equivalents will convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders unless Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The acquisition of restricted stock equivalents by a director aligns their interests with those of shareholders.

Key Dates

DateDescription
02/06/2025Date of transaction: Acquisition of restricted stock equivalents
02/06/2025Date restricted stock equivalents were acquired
02/04/2026Expiration date of the restricted stock equivalents
02/10/2025Date of signature on the Form 4 filing

Keywords

Form 4, SEC, Edgewell Personal Care, Rakesh Sachdev, restricted stock equivalents, beneficial ownership, director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.